Alnylam Pharmaceuticals, Inc.
RNAi therapeutics company with commercial rare-disease products and a late-stage cardiometabolic pipeline.
Cardiovascular & rare disease · RNA interference (RNAi) therapeutics · Commercial + Phase 3
RNAi therapeutics company with commercial rare-disease products and a late-stage cardiometabolic pipeline.
Cardiovascular & rare disease · RNA interference (RNAi) therapeutics · Commercial + Phase 3